RBC Alloimmunization in Sudanese Multi-transfused Patients
Journal of Bioscience and Applied Research · 01.03.2020 · 6 (1) · 30-37
DOI: 10.21608/jbaar.2020.115765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bioscience and Applied Research, online erschienen am 01.03.2020. Verfasst von Hager Elkobani und 2 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Blood transfusions are a life-saving measure to replace blood lost through severe bleeding or as a life-saving treatment for various hematological conditions. Blood transfusions are high-risk procedures. One of these risks is alloimmunization. Alloimmunization is an immune response to foreign antigens after exposure to genetically different cells or tissues. Alloimmunization is a frequent undesirable outcome of a blood transfusion. In this study, we investigated the frequency of alloimmunization and the factors associated with the development of antibodies infrequently transfused patients. Materials and Methods: A descriptive cross-sectional study carried out in Khartoum, Sudan between November 2017 and March 2018. The study population included 97 multi-transfused patients (Solid tumors, 41; Sickle cell anemia, 31; Leukemia; 25), 52 males and 45 females whose ages ranged between 3-81 years and each subject received a minimum of 2 units of RBCs. The number of blood units transfused varied among patients from 2 to over 20 units depending on the underline disease treatment needs. Antibody screen was performed using four-cell commercially prepared Grifols reagent RBCs and gel impregnated with antihuman globulin.
Results
The overall alloimmunization frequency was 22.7%. The alloimmunization frequency in Sickle cell anemia patients was 29.0%, solid tumors patients; 21.9%, and 16.0% in leukemic patients. Alloimmunization frequency was independent of the number of units transfused or gender (p value= 0.071, 0.942), respectively.
Conclusion
Sudanese multi-transfused patients have higher rates of alloimmunization compared to other countries. It is our recommendation that pretransfusion protocols must include antibody screening. Timely antigen typing of donor’s blood and to transfuse only antigen-negative blood.
Zitieren
APA
Elkobani, H., Elbager, S., & Bayoumi, M. (2020). RBC Alloimmunization in Sudanese Multi-transfused Patients. Journal of Bioscience and Applied Research, 6(1), 30-37. https://doi.org/10.21608/jbaar.2020.115765
Vancouver
Elkobani H, Elbager S, Bayoumi M. RBC Alloimmunization in Sudanese Multi-transfused Patients. Journal of Bioscience and Applied Research. 2020;6(1):30-37. doi:10.21608/jbaar.2020.115765
BibTeX
@article{Elkobani2020,
author = {Elkobani, Hager and Elbager, Sahar and Bayoumi, Magdi},
title = {RBC Alloimmunization in Sudanese Multi-transfused Patients},
journal = {Journal of Bioscience and Applied Research},
year = {2020},
volume = {6},
number = {1},
pages = {30--37},
doi = {10.21608/jbaar.2020.115765}
}
EUVIMED